International Journal of Phonosurgery & Laryngology

Register      Login

VOLUME 2 , ISSUE 1 ( January-June, 2012 ) > List of Articles

RESEARCH ARTICLE

Laryngopharyngeal Reflux: Prospective Study Analyzing Various Nonsurgical Treatment Modalities for LPR

Owais Mattoo, Aamir Yousuf, Anees Mir, Rahil Muzaffar, Rauf Ahmad, Aakib Hamid Charag

Citation Information : Mattoo O, Yousuf A, Mir A, Muzaffar R, Ahmad R, Charag AH. Laryngopharyngeal Reflux: Prospective Study Analyzing Various Nonsurgical Treatment Modalities for LPR. Int J Phonosurg Laryngol 2012; 2 (1):5-8.

DOI: 10.5005/jp-journals-10023-1026

Published Online: 00-06-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Objective

To compare the outcomes of various medical treatment modalities for laryngopharyngeal reflux (LPR).

Study design

Prospective study design.

Materials and methods

One-hundred and fifty patients were divided into three groups (A, B, C) based on the mode of intervention used for the control of LPR. Each study group enrolled 50 patients using random tables.

• Group A: These patients were put on a twice daily dosage of esomeprazole (20 mg bd) and domeperidone (10 mg bd) for 4 months

• Group B: These patients were put on bd dosage of esomeprazole (20 mg) and domeperidone (10 mg) and also received counseling for dietary and lifestyle changes. The duration of treatment was for 4 months.

• Group C: These patients received, in addition to above, 10 mg of amitriptyline (tricyclic antidepressant) bid, again for 4 months.

Results

The success achieved in controlling LPR was defined as greater than 50% improvement in baseline symptoms. The success achieved in group A was 46%, in group B was 54% and in group C was 40%.

The relative change in reflux symptom index (RSI) over any given period of time was significantly higher than the relative change in reflux finding score (RFS). The relative change in RSI over first month was 30.99%, which is significantly higher than the relative change of RFS (6.39%) over the same period.

The mean RSI scores during 4 months of treatment fell from 20.67 to 8.9 (p < 0.01) in group A, from 23.3 to 8.6 (p < 0.01) and from 21.3 to 10.8 (p < 0.05) in group C.

The mean RFS during 4 months fell from 15 to 6.5 (p < 0.05) in group A, from 16 to 6.4 (p < 0.05) and from 15 to 6.4 (p < 0.05) in group C.

Conclusion

• All the three interventions had a statistically significant impact on the signs and symptoms of LPR.

• However, higher success rates were achieved in group B where patients were put on a bid dosage esomeprazole and domeperidone nad counseled for lifestyle and dietary changes. Paradoxically, success rates achieved in group C was lower than other groups, possibly because of the anticholinergic effects of amitriptyline causing dry mouth and dry throat.

• The symptomatic improvement was seen much earlier than the improvement in laryngoscopic findings. This was evidenced by the fact that relative change in RSI was much higher than the relative change of RFS over a given period of time.

• If diagnosed with enough surety and certainty, patients of LPR do not need any antidepressant medications as these medications may not have any role in the treatment of same and may, however, worsen the condition owing to their anticholinergic side effects.

How to cite this article

Mattoo O, Muzaffar R, Mir A, Yousuf A Charag AH, Ahmad R. Laryngopharyngeal Reflux: Prospective Study Analyzing Various Nonsurgical Treatment Modalities for LPR. Int J Phonosurg Laryngol 2012;2(1):5-8.


PDF Share
  1. Contact ulcer of the larynx. Laryngoscope 1968 Nov;78(11):1937-40.
  2. Gastroesophageal reflux and pulmonary aspiration: Incidence, functional abnormality, and results of surgical therapy. Surgery 1979 Jul;86(1):110-19.
  3. jamiekoufman.com. 2010 [last update].
  4. heartburn-stop.com/laryngopharyngeal-reflux-diet/.
  5. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002 Dec;16(4):564-79.
  6. Omeprazole does not reduce gastroesophageal reflux: New insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004 Nov;8(7):890-97; discussion 897-98.
  7. jmat.mat.or.th. Treatment of laryngopharyngeal reflux: A comparison between domperidone plus omeprazole and omeprazole alone. J Med Assoc Thai 2012;95(1):73-80.
  8. edu. The Laryngopharyngeal Reflux 2009.
  9. Compliance with antireflux therapy in patients with otolaryngologic manifestations of gastroesophageal reflux disease. The Laryngoscope 2000 Jan;110(1):19-22.
  10. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J 2002 Sep;81(9 Suppl 2):10-13.
  11. Laryngopharyngeal reflux: Prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. The Laryngoscope 2005 July;110(7):1230-38.
  12. Laryngeal and pharyngeal complications of gastroesophageal reflux disease. GI Motility online 2006. doi: 10.1038/gimo46.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.